🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Darunavir, Ritonavir, Truvada

Found 46 matching trials

Research In Viral Eradication of HIV Reservoirs

PHASE2

This study will be a two-arm prospective 1:1 randomised controlled trial co...

Status

Completed

Location

Brighton and Sussex University Hospitals NHS Trust

Start Date

2015-11-27

Trial ID

NCT02336074

Treatments Being Tested

Combination Antiretroviral Therapy (cART)Raltegravir Vorinostat ChAdV63.HIVconsv (ChAd)MVA.HIVconsv (MVA)

A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments

PHASE4

The goal of this clinical study is to provide continued access to the study...

Status

Recruiting

Location

Helios Salud

Start Date

2024-08-27

Trial ID

NCT06337032

Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants

PHASE3

The primary objective of this study is to evaluate the efficacy of switchin...

Status

Completed

Location

University of Alabama at Birmingham

Start Date

2018-08-28

Trial ID

NCT03631732

Treatments Being Tested

B/F/TAF NRTIs Third Agent

A Study to Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes and Eliminates a Drug) of TMC125 Plus Tenofovir/Emtricitabine Once Daily With or Without Darunavir/r Once Daily in Antiretroviral (ARV) Naive HIV-1 Patients (Patients Have Never Received ARV Treatment).

PHASE2

The purpose of this study is to determine the pharmacokinetic profile of TM...

Status

Completed

Location

Multiple Locations

Start Date

2008-01

Trial ID

NCT00534352

Treatments Being Tested

TMC125; darunavir; ritonavir

Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART.

PHASE4

This is a research study into the effects of three drugs used to treat HIV ...

Status

Completed

Location

Holdsworth House Medical Practice

Start Date

2010-11

Trial ID

NCT01258439

Treatments Being Tested

raltegravir plus truvada Darunavir, ritonavir, tenofovir/emtricitabine (Truvada)

Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters

N/A

The U.S. Department of Health and Human Services (HHS) guidelines recommend...

Status

Completed

Location

USC CRS

Start Date

2009-06

Trial ID

NCT00851799

Treatments Being Tested

Emtricitabine/tenofovir disoproxil fumarate Ritonavir Atazanavir Raltegravir Darunavir

Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1

PHASE3

The purpose of this study is to assess whether maraviroc administered once ...

Status

Terminated

Location

University of Alabama at Birmingham - 1917 Research Clinic

Start Date

2011-09

Trial ID

NCT01345630

Treatments Being Tested

Maraviroc Emtricitabine/tenofovir darunavir/ritonavir 800/100 mg placebo for emtricitabine/tenofovir placebo for maraviroc

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients

PHASE3

This study will evaluate the non-inferiority of Stribild® (elvitegravir/cob...

Status

Completed

Location

Spectrum Medical Group

Start Date

2011-11

Trial ID

NCT01475838

Treatments Being Tested

PI RTV FTC/TDF Stribild

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF

PHASE3

The purpose of this randomized, open-label, multicenter, active-controlled ...

Status

Completed

Location

University of Alabama - Birmingham

Start Date

2010-11

Trial ID

NCT01252940

Treatments Being Tested

FTC/RPV/TDF PI RTV NRTIs

Metabolic Safety of Raltegravir Versus Darunavir in HIV Naive Patients

N/A

The advent of new antiretroviral drugs improved the management of HIV naive...

Status

Unknown

Location

Hospital Carlos III

Start Date

2010-02

Trial ID

NCT01066065

Previous Next